pH-Responsive Mesoporous Silica Nanoparticles Loaded with Naringin for Targeted Osteoclast Inhibition and Bone Regeneration

Shuwei Gong,Shuang Lang,Yan Wang,Xiongfeng Li,Aixian Tian,Jianxiong Ma,Xinlong Ma

DOI: https://doi.org/10.2147/ijn.s456545

IF: 7.033

2024-06-25

International Journal of Nanomedicine

Abstract:Shuwei Gong, 1, &ast Shuang Lang, 2, &ast Yan Wang, 3, &ast Xiongfeng Li, 1, &ast Aixian Tian, 3 Jianxiong Ma, 3 Xinlong Ma 3 1 Department of Orthopedics, Huzhou Central Hospital, Zhejiang University Huzhou Hospital, Huzhou, Zhejiang, 313000, People's Republic of China; 2 Department of Traditional Chinese Medicine, Huzhou Central Hospital, Zhejiang University Huzhou Hospital, Huzhou, Zhejiang, 313000, People's Republic of China; 3 Tianjin Key Laboratory of Orthopedic Biomechanics and Medical Engineering, Orthopedic Research Institute, Tianjin Hospital, Tianjin, 300050, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jianxiong Ma; Xinlong Ma, Tianjin Key Laboratory of Orthopedic Biomechanics and Medical Engineering, Orthopedic Research Institute, Tianjin Hospital, 155 Munan Road, Heping District, Tianjin, 300050, People's Republic of China, Email ; Background: It is well-established that osteoclast activity is significantly influenced by fluctuations in intracellular pH. Consequently, a pH-sensitive gated nano-drug delivery system represents a promising therapeutic approach to mitigate osteoclast overactivity. Our prior research indicated that naringin, a natural flavonoid, effectively mitigates osteoclast activity. However, naringin showed low oral availability and short half-life, which hinders its clinical application. We developed a drug delivery system wherein chitosan, as gatekeepers, coats mesoporous silica nanoparticles loaded with naringin (CS@MSNs-Naringin). However, the inhibitory effects of CS@MSNs-Naringin on osteoclasts and the underlying mechanisms remain unclear, warranting further research. Methods: First, we synthesized CS@MSNs-Naringin and conducted a comprehensive characterization. We also measured drug release rates in a pH gradient solution and verified its biosafety. Subsequently, we investigated the impact of CS@MSNs-Naringin on osteoclasts induced by bone marrow-derived macrophages, focusing on differentiation and bone resorption activity while exploring potential mechanisms. Finally, we established a rat model of bilateral critical-sized calvarial bone defects, in which CS@MSNs-Naringin was dispersed in GelMA hydrogel to achieve in situ drug delivery. We observed the ability of CS@MSNs-Naringin to promote bone regeneration and inhibit osteoclast activity in vivo. Results: CS@MSNs-Naringin exhibited high uniformity and dispersity, low cytotoxicity (concentration≤ 120 μg/mL), and significant pH sensitivity. In vitro, compared to Naringin and MSNs-Naringin, CS@MSNs-Naringin more effectively inhibited the formation and bone resorption activity of osteoclasts. This effect was accompanied by decreased phosphorylation of key factors in the NF-κB and MAPK signaling pathways, increased apoptosis levels, and a subsequent reduction in the production of osteoclast-specific genes and proteins. In vivo, CS@MSNs-Naringin outperformed Naringin and MSNs-Naringin, promoting new bone formation while inhibiting osteoclast activity to a greater extent. Conclusion: Our research suggested that CS@MSNs-Naringin exhibited the strikingly ability to anti-osteoclasts in vitro and in vivo, moreover promoted bone regeneration in the calvarial bone defect. Keywords: pH-sensitive gated nano-drug delivery system, mesoporous silica nanoparticles, naringin, chitosan, osteoclast Graphical Osteoclasts are giant multinucleated cells (nucleus ≥3) formed through the fusion of mononuclear cells that play a pivotal role in bone resorption. 1,2 Single osteoclasts live for a long time, at least 12 weeks, and about two-thirds of the cells can live up to 24 week. 3 The delicate balance between osteoblast-induced bone formation and osteoclast-induced bone resorption is vital for maintaining bone homeostasis. 1 Excessive bone resorption can disrupt the bone microstructure, leading to delayed healing of bone defects, fractures, and conditions such as osteoporosis, osteoclastoma, and Paget's disease, among others. 4 Notably, the biology of osteoclasts is closely tied to proton activity. The energy metabolism of osteoclasts is fascinating and complex. In brief, osteoclast differentiation and bone resorption require metabolic reprogramming, which requires a lot of energy and is prone to lactic acid accumulation. 5,6 Besides, they dissolve bone matrix by secreting H + into the sealing lacuna through vacuolar H + -ATPase (V-ATPase) during bone resorption. In turn, some of the released H + is then reabsorbed into the cell from the sealing lacu -Abstract Truncated-

pharmacology & pharmacy,nanoscience & nanotechnology